Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-029291
Filing Date
2024-12-13
Accepted
2024-12-13 16:15:33
Documents
1
Period of Report
2024-12-12

Document Format Files

Seq Description Document Type Size
1 form4-12132024_041217.html 4  
1 form4-12132024_041217.xml 4 4096
  Complete submission text file 0001415889-24-029291.txt   5810
Mailing Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Issuer) CIK: 0001566044 (see all company filings)

EIN.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 685 ROUTE 202/206 N, SUITE 301 BRIDGEWATER NJ 08807
Business Address
Borowski Christine (Reporting) CIK: 0002005073 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38356 | Film No.: 241548560